Published in Malar Res Treat on June 20, 2011
National malaria vector control policy: an analysis of the decision to scale-up larviciding in Nigeria. Health Policy Plan (2015) 0.78
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature (2002) 12.09
Intercontinental spread of pyrimethamine-resistant malaria. Science (2004) 8.73
Antimalarial drug resistance. J Clin Invest (2004) 8.50
Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis (2002) 5.75
Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review. Trans R Soc Trop Med Hyg (2000) 5.45
Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet (2003) 4.26
Universal access to malaria medicines: innovation in financing and delivery. Lancet (2010) 3.31
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Trop Med Int Health (2004) 3.22
High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 3.03
Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob Agents Chemother (2000) 2.68
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother (2003) 2.57
Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis (1993) 2.52
Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum. J Infect Dis (2000) 2.06
Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug. Malar J (2005) 1.85
A model for the origins and spread of drug-resistant malaria. Parasitology (1997) 1.84
High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop (2003) 1.80
Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am J Trop Med Hyg (2004) 1.64
Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. Am J Trop Med Hyg (2003) 1.59
Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda. Trop Med Int Health (2004) 1.56
Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? Trans R Soc Trop Med Hyg (2001) 1.47
Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44
Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the community. Trop Med Int Health (2005) 1.39
Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies. Malar J (2005) 1.26
How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy. J Ethnobiol Ethnomed (2006) 1.24
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine. Malar J (2010) 1.19
Polymorphisms in pfcrt, pfmdr1, dhfr genes and in vitro responses to antimalarials in Plasmodium falciparum isolates from Bangui, Central African Republic. Am J Trop Med Hyg (2006) 1.03
Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Trop Med Int Health (1998) 1.00
Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda. Trop Med Int Health (2005) 0.90
Inequities among the very poor: health care for children in rural southern Tanzania. Lancet (2003) 8.79
Intercontinental spread of pyrimethamine-resistant malaria. Science (2004) 8.73
Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets. PLoS Med (2007) 6.80
Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in Tanzania. Lancet (2004) 5.91
Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever. PLoS Med (2009) 4.49
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med (2008) 4.35
Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet (2003) 4.26
Child survival gains in Tanzania: analysis of data from demographic and health surveys. Lancet (2008) 4.03
Factors affecting home delivery in rural Tanzania. Trop Med Int Health (2007) 3.91
Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet (2005) 3.79
History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev (2004) 3.40
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Trop Med Int Health (2004) 3.22
Evaluation of Olyset insecticide-treated nets distributed seven years previously in Tanzania. Malar J (2004) 3.21
Assigning African elephant DNA to geographic region of origin: applications to the ivory trade. Proc Natl Acad Sci U S A (2004) 3.17
The use of antenatal and postnatal care: perspectives and experiences of women and health care providers in rural southern Tanzania. BMC Pregnancy Childbirth (2009) 2.95
Ageing and adult health status in eight lower-income countries: the INDEPTH WHO-SAGE collaboration. Glob Health Action (2010) 2.94
Access to health care in contexts of livelihood insecurity: a framework for analysis and action. PLoS Med (2007) 2.89
Microbial larvicide application by a large-scale, community-based program reduces malaria infection prevalence in urban Dar es Salaam, Tanzania. PLoS One (2009) 2.85
Health and survival of young children in southern Tanzania. BMC Public Health (2008) 2.83
A tool box for operational mosquito larval control: preliminary results and early lessons from the Urban Malaria Control Programme in Dar es Salaam, Tanzania. Malar J (2008) 2.70
The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop (2005) 2.64
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother (2003) 2.57
Interdependence of domestic malaria prevention measures and mosquito-human interactions in urban Dar es Salaam, Tanzania. Malar J (2007) 2.57
The use of personal digital assistants for data entry at the point of collection in a large household survey in southern Tanzania. Emerg Themes Epidemiol (2007) 2.53
Conservation. Elephants, ivory, and trade. Science (2010) 2.51
Mosquito nets and the poor: can social marketing redress inequities in access? Trop Med Int Health (2004) 2.44
Development and field evaluation of a synthetic mosquito lure that is more attractive than humans. PLoS One (2010) 2.42
Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter? Health Policy Plan (2007) 2.35
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Malar J (2007) 2.30
Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis (2006) 2.26
Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme. Malar J (2007) 2.25
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One (2009) 2.18
Randomized controlled safety and efficacy trial of 2 vitamin A supplementation schedules in Tanzanian infants. Am J Clin Nutr (2007) 2.11
Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am J Trop Med Hyg (2010) 2.03
The changing epidemiology of malaria in Ifakara Town, southern Tanzania. Trop Med Int Health (2004) 2.02
Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions -- a user perspective. Malar J (2010) 2.00
A framework for mandatory impact evaluation to ensure well informed public policy decisions. Lancet (2010) 1.97
Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. J Infect Dis (2008) 1.96
Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med (2007) 1.93
Establishment of a large semi-field system for experimental study of African malaria vector ecology and control in Tanzania. Malar J (2008) 1.93
Vouchers for scaling up insecticide-treated nets in Tanzania: methods for monitoring and evaluation of a national health system intervention. BMC Public Health (2008) 1.86
Obstacles to prompt and effective malaria treatment lead to low community-coverage in two rural districts of Tanzania. BMC Public Health (2008) 1.85
Rift Valley fever outbreak in livestock in Kenya, 2006-2007. Am J Trop Med Hyg (2010) 1.78
The transit phase of migration: circulation of malaria and its multidrug-resistant forms in Africa. PLoS Med (2011) 1.78
Participatory mapping of target areas to enable operational larval source management to suppress malaria vector mosquitoes in Dar es Salaam, Tanzania. Int J Health Geogr (2007) 1.77
Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J (2010) 1.77
Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda. J Infect Dis (2008) 1.73
Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. Am J Trop Med Hyg (2004) 1.72
Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania. Malar J (2006) 1.72
Markets, voucher subsidies and free nets combine to achieve high bed net coverage in rural Tanzania. Malar J (2008) 1.68
Ecologists can enable communities to implement malaria vector control in Africa. Malar J (2006) 1.63
Association of sub-microscopic malaria parasite carriage with transmission intensity in north-eastern Tanzania. Malar J (2011) 1.63
Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria. Trends Parasitol (2013) 1.61
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg (2002) 1.60
Understanding home-based neonatal care practice in rural southern Tanzania. Trans R Soc Trop Med Hyg (2008) 1.57
Using DNA to track the origin of the largest ivory seizure since the 1989 trade ban. Proc Natl Acad Sci U S A (2007) 1.56
Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania. Malar J (2008) 1.55
Health inequalities among older men and women in Africa and Asia: evidence from eight Health and Demographic Surveillance System sites in the INDEPTH WHO-SAGE Study. Glob Health Action (2010) 1.54
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis (2012) 1.53
Following the path of most resistance: dhps K540E dispersal in African Plasmodium falciparum. Trends Parasitol (2010) 1.53
Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness. Trop Med Int Health (2006) 1.50
Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania. Malar J (2006) 1.48
Malaria risk and access to prevention and treatment in the paddies of the Kilombero Valley, Tanzania. Malar J (2008) 1.43
Risk factors for presentation to hospital with severe anaemia in Tanzanian children: a case-control study. Trop Med Int Health (2002) 1.43
The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania. Malar J (2008) 1.40
Risk factors for surgical site infection in a Tanzanian district hospital: a challenge for the traditional National Nosocomial Infections Surveillance system index. Infect Control Hosp Epidemiol (2006) 1.39
A large cross-sectional community-based study of newborn care practices in southern Tanzania. PLoS One (2010) 1.38
Performance of HRP-2 based rapid diagnostic test for malaria and its variation with age in an area of intense malaria transmission in southern Tanzania. Malar J (2010) 1.37
Out-of-pocket payments for under-five health care in rural southern Tanzania. Health Policy Plan (2005) 1.37
Socio-cultural factors explaining timely and appropriate use of health facilities for degedege in south-eastern Tanzania. Malar J (2009) 1.36
Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum. Mol Biol Evol (2005) 1.36
Impact of Integrated Management of Childhood Illness on inequalities in child health in rural Tanzania. Health Policy Plan (2005) 1.35
Human resources for health care delivery in Tanzania: a multifaceted problem. Hum Resour Health (2012) 1.34
Combating the illegal trade in African elephant ivory with DNA forensics. Conserv Biol (2008) 1.34
Malaria treatment in the retail sector: knowledge and practices of drug sellers in rural Tanzania. BMC Public Health (2008) 1.31
Drug resistance maps to guide intermittent preventive treatment of malaria in African infants. Parasitology (2011) 1.28
Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies. Malar J (2005) 1.26
Concentration and drug prices in the retail market for malaria treatment in rural Tanzania. Health Econ (2009) 1.25
Associations between alpha+-thalassemia and Plasmodium falciparum malarial infection in northeastern Tanzania. J Infect Dis (2007) 1.25
Urban agriculture and Anopheles habitats in Dar es Salaam, Tanzania. Geospat Health (2009) 1.24
From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control. BMC Health Serv Res (2008) 1.22
A point mutation in codon 76 of pfcrt of P. falciparum is positively selected for by Chloroquine treatment in Tanzania. Infect Genet Evol (2002) 1.21
Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola. Trop Med Int Health (2009) 1.19
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine. Malar J (2010) 1.19
Health system support for childbirth care in Southern Tanzania: results from a health facility census. BMC Res Notes (2013) 1.15
Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing. J Acquir Immune Defic Syndr (2007) 1.14
The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania. Malar J (2008) 1.13
Health status and quality of life among older adults in rural Tanzania. Glob Health Action (2010) 1.11
Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum. Malar J (2013) 1.11